Sign up to save your podcasts
Or
Share Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York, New York, discuss approved and novel bispecific antibodies and their current and potential roles in the treatment of multiple myeloma.
View all episodes
By Dr. Neil Love
4.4
7272 ratings
Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York, New York, discuss approved and novel bispecific antibodies and their current and potential roles in the treatment of multiple myeloma.
More shows like Hematologic Oncology Update
View all
NEJM This Week
321 Listeners
JAMA Clinical Reviews
495 Listeners
Breast Cancer Update
66 Listeners
Lung Cancer Update
31 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
115 Listeners
The Hematologist
26 Listeners
Mayo Clinic Talks
292 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
The ONS Podcast
197 Listeners
Blood Podcast
54 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Blood Cancer Talks
48 Listeners
Two Onc Docs
189 Listeners
WolverHeme Happy Hour
30 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners